Cantel Medical Corp. (CMN) Stake Increased by UBS Asset Management Americas Inc.
UBS Asset Management Americas Inc. boosted its position in Cantel Medical Corp. (NYSE:CMN) by 0.7% during the second quarter, Holdings Channel reports. The fund owned 23,099 shares of the company’s stock after buying an additional 163 shares during the period. UBS Asset Management Americas Inc. owned 0.06% of Cantel Medical Corp. worth $1,588,000 as of its most recent filing with the SEC.
A number of other large investors have also recently added to or reduced their stakes in CMN. LS Investment Advisors LLC boosted its stake in Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock worth $104,000 after buying an additional 106 shares during the last quarter. BlackRock Inc. raised its stake in shares of Cantel Medical Corp. by 119.5% in the first quarter. BlackRock Inc. now owns 2,355 shares of the company’s stock worth $168,000 after buying an additional 1,282 shares during the period. Bank of Montreal Can bought a new stake in shares of Cantel Medical Corp. during the second quarter worth about $203,000. Cypress Wealth Advisors LLC bought a new stake in shares of Cantel Medical Corp. during the first quarter worth about $210,000. Finally, Mariner Wealth Advisors LLC bought a new stake in shares of Cantel Medical Corp. during the first quarter worth about $216,000. Institutional investors own 81.60% of the company’s stock.
Shares of Cantel Medical Corp. (NYSE:CMN) traded up 0.50% during midday trading on Wednesday, reaching $77.03. 8,931 shares of the company’s stock were exchanged. The company’s 50-day moving average is $77.54 and its 200-day moving average is $71.14. The stock has a market cap of $3.19 billion, a P/E ratio of 53.57 and a beta of 1.59. Cantel Medical Corp. has a one year low of $53.64 and a one year high of $81.63.
Cantel Medical Corp. (NYSE:CMN) last released its quarterly earnings results on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The company earned $179 million during the quarter. During the same period last year, the firm earned $0.39 earnings per share. The business’s revenue was up 18.3% compared to the same quarter last year. Equities analysts expect that Cantel Medical Corp. will post $1.98 earnings per share for the current fiscal year.
CMN has been the subject of a number of research analyst reports. Benchmark Co. initiated coverage on shares of Cantel Medical Corp. in a report on Monday, August 29th. They set a “buy” rating and a $83.00 price objective for the company. Needham & Company LLC initiated coverage on shares of Cantel Medical Corp. in a report on Wednesday, August 24th. They set a “hold” rating for the company.
In other news, Director Ann E. Berman sold 1,453 shares of the business’s stock in a transaction on Friday, September 30th. The stock was sold at an average price of $77.56, for a total value of $112,694.68. Following the completion of the transaction, the director now directly owns 5,424 shares of the company’s stock, valued at $420,685.44. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Chairman Charles M. Diker sold 14,897 shares of the business’s stock in a transaction on Monday, October 10th. The stock was sold at an average price of $78.76, for a total value of $1,173,287.72. Following the completion of the transaction, the chairman now directly owns 3,190,111 shares of the company’s stock, valued at $251,253,142.36. The disclosure for this sale can be found here. 15.30% of the stock is owned by insiders.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Want to see what other hedge funds are holding CMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMN).
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.